Lucinactant for inhalation
03-CL-1401
Phase 2 other terminated
Quick answer
Lucinactant for inhalation for Respiratory Distress Syndrome is a Phase 2 program (other) at WINDTREE THERAPEUTICS INC /DE/ with 2 ClinicalTrials.gov record(s).
Program details
- Company
- WINDTREE THERAPEUTICS INC /DE/
- Indication
- Respiratory Distress Syndrome
- Phase
- Phase 2
- Modality
- other
- Status
- terminated